MyFinsight
Home
Blog
About
Aclarion, Inc. (ACON)
Aclarion, Inc. (ACON)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$2,719,514
Free Cash flow
-$2,658,859
Unit: Dollar
Positive Cash Flow Breakdown
Accounts payable
Depreciation and amortization
Accounts receivable
Negative Cash Flow Breakdown
Net loss
Prepaids and other current asset...
Accrued and other liabilities
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-2,747,551
-2,853,575
-1,889,142
-1,706,294
Depreciation and amortization
61,869
60,909
61,313
58,364
Share-based compensation
102,117
4,694
4,365
16,746
Amendment of warrants
0
0
0
0
Non-cash settlements
0
0
0
0
Loss on exchange of debt
-
-
0
0
Loss on extinguishment of debt
-
-
0
0
Amortization of deferred issuance costs
-
-
0
0
Change in fair value related to warrants and derivative
0
-18
-39
-1
Non-cash interest related to bridge funding
-
-
0
0
Non-cash expenses related to equity line agreement
-
-
0
-
Accounts receivable
-12,411
10,903
-2,338
11,097
Prepaids and other current assets
149,582
-20,243
-180,157
-68,011
Accounts payable
130,647
242,195
15,366
54,230
Accrued and other liabilities
-66,962
-105,390
-1,796
359,669
Note payable, net of discount
-
-
-
0
Net cash used in operating activities
-2,657,051
-2,641,845
-1,627,438
-1,160,372
Intangible assets patents
41,371
49,345
27,735
32,829
Fixed assets
1,808
-
13,726
7,321
Net cash used in investing activities
-43,179
-49,345
-41,461
-40,151
Public offering of common stock and warrants
0
0
0
0
Registered direct offerings of common stock
0
1,036,000
535,041
0
Proceeds from direct offering of prefunded warrants
0
9,323,982
1,972,957
-
Proceeds from sale of preferred stock
-
-
0
-
Proceeds from sale of common stock and warrants, atm
-
-
0
-
Common stock cash issuance costs
19,284
679,605
164,646
283,798
Exercise of series c warrants
0
0
0
0
Redemption of series b preferred stock
0
0
0
0
Issuance of common stock and warrants related to public offering, net deductions
-
-
-
0
Proceeds from common stock and warrant rega+ offering
-
-
0
0
Proceeds from sales of c-series preferred stock and warrants
-
-
-
0
Proceeds from equity line
-
-
0
0
Repayment of promissory notes
-
-
0
0
Bridge fund cash issuance costs
-
-
-
0
Equity line cash issuance costs
-
-
0
-
Preferred stock cash issuance costs
-
-
0
0
Net cash provided by financing activities
-19,284
9,680,377
2,343,352
-283,798
Net increase in cash, cash equivalents and restricted cash
-2,719,514
6,989,187
674,453
-1,484,321
Cash, cash equivalents and restricted cash, beginning of period
19,029,976
12,040,789
11,366,336
463,661
Cash, cash equivalents and restricted cash, end of period
16,310,462
19,029,976
12,040,789
11,366,336
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net increase in
cash, cash...
-$2,719,514
(-121.95%↓ Y/Y)
Accounts payable
$130,647
(148.71%↑ Y/Y)
Share-based compensation
$102,117
(21.20%↑ Y/Y)
Depreciation and
amortization
$61,869
(-42.57%↓ Y/Y)
Accounts receivable
-$12,411
(-578.27%↓ Y/Y)
Net cash used in
operating activities
-$2,657,051
(39.29%↑ Y/Y)
Net cash used in
investing activities
-$43,179
(64.69%↑ Y/Y)
Net cash provided by
financing activities
-$19,284
(-100.11%↓ Y/Y)
Canceled cashflow
$307,044
Net loss
-$2,747,551
(24.48%↑ Y/Y)
Intangible assets patents
$41,371
(-66.04%↓ Y/Y)
Fixed assets
$1,808
(275.88%↑ Y/Y)
Common stock cash
issuance costs
$19,284
(-99.02%↓ Y/Y)
Prepaids and other
current assets
$149,582
(-35.56%↓ Y/Y)
Accrued and other
liabilities
-$66,962
(87.17%↑ Y/Y)
Buy us a coffee